23-epi-26-Deoxyactein

CAS No. 264624-38-6

23-epi-26-Deoxyactein ( 27-Deoxyactein )

Catalog No. M24175 CAS No. 264624-38-6

23-epi-26-Deoxyactein has anti-inflammatory activity, it inhibits nitric oxide production by reducing iNOS expression without affecting activity of the enzyme. It also has anti-cancer activity, it can inhibit growth of the MCF7 human breast cancer cells and induce cell cycle arrest at G1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 300 In Stock
10MG 511 In Stock
25MG 807 In Stock
50MG 1062 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    23-epi-26-Deoxyactein
  • Note
    Research use only, not for human use.
  • Brief Description
    23-epi-26-Deoxyactein has anti-inflammatory activity, it inhibits nitric oxide production by reducing iNOS expression without affecting activity of the enzyme. It also has anti-cancer activity, it can inhibit growth of the MCF7 human breast cancer cells and induce cell cycle arrest at G1.
  • Description
    23-epi-26-Deoxyactein has anti-inflammatory activity, it inhibits nitric oxide production by reducing iNOS expression without affecting activity of the enzyme. It also has anti-cancer activity, it can inhibit growth of the MCF7 human breast cancer cells and induce cell cycle arrest at G1.
  • Synonyms
    27-Deoxyactein
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    CDK;NO Synthase;NOS
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    264624-38-6
  • Formula Weight
    660.8
  • Molecular Formula
    C37H56O10
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@H](C[C@]1(OC[C@@]2(C)O[C@@H]12)O[C@H]1C2)[C@@H]1[C@@](C)([C@@H](C1)OC(C)=O)[C@]2(C)[C@H](CC2)[C@]1(C1)[C@@]1(CC1)[C@@H]2C(C)(C)[C@H]1O[C@@H]([C@@H]([C@H]1O)O)OC[C@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Growth inhibitory activity of extracts and purified components of black cohosh on human breast cancer cells.Breast Cancer Res Treat. 2004 Feb;83(3):221-31.
molnova catalog
related products
  • CDK9-IN-2

    CDK9-IN-2 is a potent and selective CDK9 inhibitor with IC50 of <8 nM, example 4 in patent WO2011026917A1.

  • PF07104091

    PF-07104091 inhibits CDK2, which may lead to cell cycle arrest, induce apoptosis and inhibit tumor cell proliferation.

  • FN-1501

    FN-1501 is a potent FLT3 and CDK inhibitor (IC50s: 2.47, 0.85, 1.96, and 0.28 nM for CDK2/cyclin A, CDK4/cyclin D1, CDK6/cyclin D1 and FLT3, respectively).